Candida infections are varied and, depending on the immune status of the patient, a life-
threatening form may develop. C. albicans is the most prevalent species isolated, however …

(1) Background: In recent years, a global epidemiological shift in candidemia has been
observed, marked by the emergence of resistant non-albicans Candida species. Candida …

Neonatal invasive candidiasis (NIC) has significant morbidity and mortality. Reports have
shown a different profile of those neonates affected with NIC and of fluconazole-resistant …

During the past decade, Candida auris emerged across the world, causing nosocomial
outbreaks in both pediatric and adult populations, particularly in intensive care settings. We …

Invasive Candida infections represent a significant cause of morbidity and mortality in
neonatal intensive care units (NICUs), with a particular impact on preterm and low-birth …

A “one health” approach recognises that human health, animal health and planetary health
are closely interlinked and that a transdisciplinary approach is required to fully understand …

Invasive Candida infections represent a significant cause of morbidity and mortality in the
neonatal intensive care unit (NICU), particularly among preterm and low birth weight …

Candida auris is a multidrug-resistant, difficult-to-eradicate pathogen that can colonize
patients and health-care environments and cause severe infections and nosocomial …

Introduction: Invasive fungal infections affecting the central nervous system (CNS) are a
major health concern worldwide associated with high mortality rates. Their increased …

Candida albicans is the most frequent cause of invasive fungal disease in preterm and/or
low birth weight neonates, followed by Candida parapsilosis, whilst infections from other …